Titre : Régulon

Régulon : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prothrombin Time
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Régulon : Questions médicales les plus fréquentes", "headline": "Régulon : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Régulon : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-26", "dateModified": "2025-03-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Régulon" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composants de génome", "url": "https://questionsmedicales.fr/mesh/D040481", "about": { "@type": "MedicalCondition", "name": "Composants de génome", "code": { "@type": "MedicalCode", "code": "D040481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.024" } } }, "about": { "@type": "MedicalCondition", "name": "Régulon", "alternateName": "Regulon", "code": { "@type": "MedicalCode", "code": "D018085", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bernhard O Palsson", "url": "https://questionsmedicales.fr/author/Bernhard%20O%20Palsson", "affiliation": { "@type": "Organization", "name": "Department of Bioengineering, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Ye Gao", "url": "https://questionsmedicales.fr/author/Ye%20Gao", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Yara Seif", "url": "https://questionsmedicales.fr/author/Yara%20Seif", "affiliation": { "@type": "Organization", "name": "Department of Bioengineering, University of California San Diego , La Jolla, California, USA." } }, { "@type": "Person", "name": "Doron Teper", "url": "https://questionsmedicales.fr/author/Doron%20Teper", "affiliation": { "@type": "Organization", "name": "Citrus Research and Education Center, Department of Microbiology and Cell Sciences, University of Florida, 700 Experiment Station Road, Lake Alfred FL 33850, U.S.A." } }, { "@type": "Person", "name": "Nian Wang", "url": "https://questionsmedicales.fr/author/Nian%20Wang", "affiliation": { "@type": "Organization", "name": "Citrus Research and Education Center, Department of Microbiology and Cell Sciences, University of Florida, 700 Experiment Station Road, Lake Alfred FL 33850, U.S.A." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!", "datePublished": "2023-06-17", "url": "https://questionsmedicales.fr/article/37374373", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/medicina59061169" } }, { "@type": "ScholarlyArticle", "name": "Comparative analysis on characteristics of two activated partial thromboplastin time reagents.", "datePublished": "2022-07-19", "url": "https://questionsmedicales.fr/article/35853032", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jcla.24608" } }, { "@type": "ScholarlyArticle", "name": "The utility of the dilute prothrombin time in the interpretation of antiphospholipid syndrome testing.", "datePublished": "2024-05-14", "url": "https://questionsmedicales.fr/article/38741421", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/ajcp/aqae044" } }, { "@type": "ScholarlyArticle", "name": "Role of Electrode Configuration and Morphology in Printed Prothrombin Time Sensors.", "datePublished": "2023-10-14", "url": "https://questionsmedicales.fr/article/37953965", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.snb.2023.134785" } }, { "@type": "ScholarlyArticle", "name": "Falsely prolonged prothrombin time test in a patient with erythrocytosis: a case report.", "datePublished": "2024-01-26", "url": "https://questionsmedicales.fr/article/38305118", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001276" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Composants de génome", "item": "https://questionsmedicales.fr/mesh/D040481" }, { "@type": "ListItem", "position": 6, "name": "Régulon", "item": "https://questionsmedicales.fr/mesh/D018085" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Régulon - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Régulon", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Régulon", "description": "Comment savoir si le Régulon est adapté ?\nQuels tests sont nécessaires avant de commencer le Régulon ?\nLe Régulon nécessite-t-il un suivi médical ?\nQuels signes indiquent une mauvaise tolérance au Régulon ?\nLe Régulon est-il efficace dès le premier jour ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Prothrombin+Time&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Régulon", "description": "Quels sont les effets secondaires courants du Régulon ?\nLe Régulon peut-il provoquer des douleurs abdominales ?\nComment reconnaître une réaction allergique au Régulon ?\nLe Régulon peut-il affecter l'humeur ?\nQuels symptômes nécessitent d'arrêter le Régulon ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Prothrombin+Time&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Régulon", "description": "Comment le Régulon prévient-il la grossesse ?\nLe Régulon est-il efficace pour réguler le cycle menstruel ?\nQuels conseils pour maximiser l'efficacité du Régulon ?\nLe Régulon peut-il être utilisé comme traitement hormonal ?\nEst-il nécessaire de consulter un médecin avant de commencer le Régulon ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Prothrombin+Time&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Régulon", "description": "Comment prendre le Régulon correctement ?\nQue faire en cas d'oubli d'une pilule ?\nLe Régulon peut-il être pris avec d'autres médicaments ?\nCombien de temps peut-on prendre le Régulon ?\nLe Régulon protège-t-il contre les IST ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Prothrombin+Time&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Régulon", "description": "Quelles sont les complications possibles du Régulon ?\nComment reconnaître un caillot sanguin lié au Régulon ?\nLe Régulon augmente-t-il le risque de cancer ?\nQuels signes d'AVC doivent alerter ?\nLe Régulon peut-il causer des problèmes de foie ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Prothrombin+Time&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Régulon", "description": "Qui devrait éviter le Régulon ?\nLe tabagisme influence-t-il l'utilisation du Régulon ?\nLes femmes obèses doivent-elles être prudentes avec le Régulon ?\nLes antécédents familiaux de cancer influencent-ils le choix ?\nLe Régulon est-il sûr pour les femmes âgées ?", "url": "https://questionsmedicales.fr/mesh/D018085?mesh_terms=Prothrombin+Time&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment savoir si le Régulon est adapté ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un médecin évalue l'historique médical et les besoins contraceptifs." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant de commencer le Régulon ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique et éventuellement des tests sanguins pour vérifier la santé." } }, { "@type": "Question", "name": "Le Régulon nécessite-t-il un suivi médical ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi est recommandé pour évaluer l'efficacité et les effets secondaires." } }, { "@type": "Question", "name": "Quels signes indiquent une mauvaise tolérance au Régulon ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des saignements irréguliers ou des nausées persistantes." } }, { "@type": "Question", "name": "Le Régulon est-il efficace dès le premier jour ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est efficace immédiatement si pris au début du cycle menstruel." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants du Régulon ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Nausées, maux de tête, changements d'humeur et saignements irréguliers." } }, { "@type": "Question", "name": "Le Régulon peut-il provoquer des douleurs abdominales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines femmes peuvent ressentir des douleurs abdominales légères." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique au Régulon ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, éruptions cutanées ou gonflements peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Le Régulon peut-il affecter l'humeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements d'humeur peuvent survenir en raison des hormones." } }, { "@type": "Question", "name": "Quels symptômes nécessitent d'arrêter le Régulon ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, des maux de tête sévères ou des troubles de la vision." } }, { "@type": "Question", "name": "Comment le Régulon prévient-il la grossesse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il empêche l'ovulation et rend la muqueuse utérine moins réceptive aux spermatozoïdes." } }, { "@type": "Question", "name": "Le Régulon est-il efficace pour réguler le cycle menstruel ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut aider à réguler les cycles menstruels irréguliers chez certaines femmes." } }, { "@type": "Question", "name": "Quels conseils pour maximiser l'efficacité du Régulon ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Prenez-le à la même heure chaque jour et évitez les interactions médicamenteuses." } }, { "@type": "Question", "name": "Le Régulon peut-il être utilisé comme traitement hormonal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être prescrit pour traiter des troubles hormonaux comme l'endométriose." } }, { "@type": "Question", "name": "Est-il nécessaire de consulter un médecin avant de commencer le Régulon ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consultation médicale est essentielle pour évaluer les risques et bénéfices." } }, { "@type": "Question", "name": "Comment prendre le Régulon correctement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Prenez un comprimé chaque jour à la même heure pour une efficacité optimale." } }, { "@type": "Question", "name": "Que faire en cas d'oubli d'une pilule ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Prenez la pilule oubliée dès que possible, mais ne doublez pas la dose." } }, { "@type": "Question", "name": "Le Régulon peut-il être pris avec d'autres médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent interférer avec le Régulon, consultez un médecin." } }, { "@type": "Question", "name": "Combien de temps peut-on prendre le Régulon ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il peut être pris pendant plusieurs années, mais un suivi médical est nécessaire." } }, { "@type": "Question", "name": "Le Régulon protège-t-il contre les IST ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, le Régulon ne protège pas contre les infections sexuellement transmissibles." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du Régulon ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des caillots sanguins, AVC ou hypertension." } }, { "@type": "Question", "name": "Comment reconnaître un caillot sanguin lié au Régulon ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs soudaines dans la jambe, gonflement ou rougeur peuvent indiquer un caillot." } }, { "@type": "Question", "name": "Le Régulon augmente-t-il le risque de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent un risque légèrement accru de cancer du sein, mais les données sont variées." } }, { "@type": "Question", "name": "Quels signes d'AVC doivent alerter ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des maux de tête soudains, troubles de la parole ou paralysie d'un côté du corps." } }, { "@type": "Question", "name": "Le Régulon peut-il causer des problèmes de foie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles hépatiques peuvent survenir, surtout chez les femmes avec antécédents." } }, { "@type": "Question", "name": "Qui devrait éviter le Régulon ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes avec des antécédents de caillots sanguins ou AVC devraient l'éviter." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il l'utilisation du Régulon ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de complications cardiovasculaires avec le Régulon." } }, { "@type": "Question", "name": "Les femmes obèses doivent-elles être prudentes avec le Régulon ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité peut augmenter le risque de complications liées au Régulon." } }, { "@type": "Question", "name": "Les antécédents familiaux de cancer influencent-ils le choix ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer peuvent nécessiter une évaluation plus approfondie." } }, { "@type": "Question", "name": "Le Régulon est-il sûr pour les femmes âgées ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes de plus de 35 ans, surtout fumeuses, doivent consulter un médecin avant de l'utiliser." } } ] } ] }

Sources (10000 au total)

Comparative analysis on characteristics of two activated partial thromboplastin time reagents.

For the lack of standardized activated partial thromboplastin time (APTT), it has been pointed out that there are differences in values among several reagents. Recently, we have performed a parallel m... In order to clarify the factors related to ΔAPTT, multiple regression analysis was performed on 8324 samples, using clinical laboratory data of all test items requested simultaneously with APTT. To co... Multiple regression analysis detected albumin-globulin ratio (AGR), C-reactive protein (CRP), hematocrit, and prothrombin time as factors related to ΔAPTT (p < 0.001). Results revealed no significant ... It is considered that the pseudo-prolongation of APTT is triggered by the interaction of CRP on the phospholipid in Coagpia APTT-n, which contributed to the APTT dissociation....

The utility of the dilute prothrombin time in the interpretation of antiphospholipid syndrome testing.

To evaluate the utility of the dilute prothrombin time (DPT) in diagnosing antiphospholipid syndrome (APS), alone and when paired with the dilute Russell viper venom time (DRVVT).... Dilute prothrombin time and DRVVT testing was performed on plasma samples spiked with apixaban or rivaroxaban, or depleted of vitamin K-dependent clotting factors. A retrospective analysis of all func... In spiking studies, the screening clotting time in the DPT (DPTS) is more sensitive to deficiency of vitamin K-dependent factors than is the screening clotting time in the DRVVT (DRVVTS). The converse... Dilute prothrombin time lupus anticoagulant assay is rarely the sole laboratory functional evidence for APS, but when combined with the DRVVT, the DPT can serve as an effective screen for common antic...

Prothrombin complex concentrate administration timing in warfarin-associated intracranial hemorrhage.

Guidelines recommend "rapid" and "urgent" reversal of anticoagulation for warfarin-associated intracranial hemorrhage (ICH) treatment; however, they do not specify goals for time-to-administration. Th... This was a retrospective, observational, single center study performed at a large community teaching hospital. Patients were stratified into three groups based on time of CT diagnosis of ICH to admini... A total of 227 patients were screened for inclusion with ultimately 39 being included. Baseline characteristics were similar between groups. The primary outcome was not significantly different among g... There was no association with time-to-administration of 4F-PCC on rates of hemostasis achievement, defined as hematoma expansion of ≤20%, identified in this study....

Prothrombin time predicts steroid response in severe alcohol-related hepatitis.

Alcohol-related hepatitis (AH) is the most severe form of acute alcohol-related liver disease. Maddrey's discriminant function ≥32 defines the severe form of AH, which is associated with a high mortal... Patients consecutively admitted in two Italian Liver Units, from 2017 to 2022, suffering from sAH were included. Data were collected prospectively. In order to evaluate if BPT could predict steroid re... A total of 52 patients received steroid treatment were enrolled in the study. The response to therapy was assessed by Lille score at day 7. Responders were 34 patients (65%), non-responders 18 patient... BPT value predicted steroid response in patients with sAH. BPT could quickly identify non-responder patients to steroid therapy, reducing the risk of infections and it could allow the early evaluation...

Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients.

Genotype-guided dosing algorithms can explain about half of the interindividual variability in prothrombin time-international normalized ratio (PT-INR) under warfarin treatment. This study aimed to re... Using a retrospective cohort of adult patients (>20 years) who were administered warfarin and underwent PT-INR measurements, we refined the kinetic-pharmacodynamic model with age and the genotypes of ... A total of 350 patients with 2762 PT-INR measurements were enrolled (estimated glomerular filtration rate [eGFR]: 47.5 [range: 2.6-199.0] mL/min/1.73 m... Model-informed precision dosing of warfarin is a valuable approach for estimating its dosage in patients with renal impairment....